health – Page 5 – Market Industry Forecast News

Buttock Augmentation Market Key Insights: Navigating Emerging Trends

The global buttock augmentation market size is anticipated to reach USD 11.72 billion by 2030, according to the new report of Grand View Research, Inc. The market is expected to expand at a CAGR of 21.5% from 2024 to 2030. Buttock augmentation also called gluteal augmentation is a technique used to contour, size, and enhance the appearance. A buttock lift is reported to improve the tone of the underlying tissue and is mainly done by using implants, fat grafting, or sometimes a combination of the two.

Factors like rising technological advancement in aesthetics, rising disposable income, increasing aesthetic consciousness and the high success rate of augmentation procedures are propelling the market growth. According to the International Society of Aesthetic Plastic Surgery, around 5, 34,345 butt augmentation and lift procedures were carried out globally in 2019. Buttock augmentation accounts for 4.7% of total surgical procedures globally.

Access the Buttock Augmentation Market Size, Share & Trends Analysis Report By Procedure (Buttock Implants, Buttock Injections), By End-use (Hospitals, Aesthetic Clinics), By Region, And Segment Forecasts, 2024 – 2030

Growing social media influence, high consciousness towards aesthetic appearance, and its association with self-confidence and self-image by an individual are some of the reasons for market growth. In the light of COVID-19, the market was hampered as patient appointments for surgical treatments were temporarily suspended. However, since the government in many countries has allowed resuming elective surgical procedures, clinics have also started buttock lift and grafting procedures again. Moreover, according to the BBC network, inquiries and appointments for many surgical and non-surgical cosmetic treatments have seen a surge following the pandemic and are thus expected to propel market growth.

Buttock Augmentation Market Report Highlights

By procedure, the buttock implant procedure segment held the largest revenue share in 2023 as techniques like fat grafting and butt lift are more in demand and has faster post-operative healing

Based on implant type, the fat grafting segment accounted for the largest revenue share in 2023 as this procedure is less complicated, takes less operative time, and has more success rate

In North America, the market accounted for the largest revenue share in 2023 as the region has a high awareness of such procedure and there is high availability of aesthetic professionals

In Asia Pacific, the market is expected to grow significantly in the forecast period owing to technological advancements and an increase in patients opting for procedures to improve aesthetic appearances

Order your free sample copy of “Buttock Augmentation Market Report 2024 – 2030, published by Grand View Research

Key Buttock Augmentation Company Insights

Some of the companies key companies in global buttock augmentation market are Abbvie (AllerganAesthetics), GC Aesthetics, Sebbin, and other. To develop a competitive edge over others, the key companies have embraced strategies such as innovation.

Allergan Aesthetics, a subsidiary of the global pharmaceutical organization AbbiVie, develops, manufactures, and distributes offerings related to body contouring, facial injectables, skin care, and plastics. The company also invests heavily in research and development activities to deliver innovation-backed products. It is headquartered in Irvine, California, and has several manufacturing sites across multiple locations around the world.

GC Aesthetics, one of the prominent players in aesthetic enhancements and pre & post-surgery solutions, primarily delivers offerings related to breast enhancements, face implants, body implants, and Remote Valve Tissue Expanders (RVTEs).

Key Buttock Augmentation Companies:

The following are the leading companies in the buttock augmentation market. These companies collectively hold the largest market share and dictate industry trends.

Abbvie. (AllerganAesthetics)
Dermax Co. Ltd.
GC Aesthetics
Implantech
Sientra Inc.
Sebbin
Merz Pharma
Alpha Aesthetics
Hanson Medical Inc.
GALDERMA 2024
CGBio

About Grand View Research:

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies, ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials, and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights. For more information, visit www.grandviewresearch.com

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

Polynucleotides Injectable Market Drivers: Surge in Cosmetic Enhancements

The global polynucleotides injectable market size is expected to reach USD 293.4 million by 2030, and is projected to grow at a CAGR of 14.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The technological advancements in the biotechnology sector primarily drive the market growth. The increasing demand for personalized medicine, skin rejuvenation, and investments in R&D are also major factors for market growth.

The global population’s growing interest in minimally invasive cosmetic treatments has led to a surge in demand for alternatives to surgical interventions. Polynucleotide injectables offer a non-invasive way to regenerate the skin and address age-related issues, favoring their popularity in the medical aesthetics industry. With the global population steadily aging, there is a heightened demand for products and treatments that can combat the visible signs of aging. Polynucleotide injectables provide a natural and effective solution for reducing fine lines, wrinkles, and sagging skin while promoting long-term skin health.

The report “Polynucleotides Injectable Market Size, Share & Trends Analysis Report By Application (Eyes, Lips), By End-use (MedSpas, Aesthetic & Cosmetic Centers), By Region, and Segment Forecasts, 2024 – 2030” is available now to Grand View Research customers and can also be purchased directly

Continuous innovations in regional regenerative medicine are unlocking new therapeutic applications for polynucleotide injectables. These advertisements not only expand their use in cosmetic procedures but also open up new possibilities for treating a variety of conditions, such as joint damage, tendonitis, and ligament injuries. Consumers are becoming more informed about the safety and efficacy of treatments. Polynucleotides are naturally derived and are considered safe with a low risk of allergic reactions or complications, making them an attractive option for patients seeking safe nonsynthetic solutions.

The potential for expansion into new therapeutic areas presents substantial opportunities. Beyond cosmetic treatments, the use of polynucleotide injectables in orthopedic conditions, chronic wounds, and tissue regeneration offers an untapped market with significant growth potential. As clinical studies continue to demonstrate the efficacy of polynucleotides in a broader range of applications, the market is poised for accelerated growth.

Polynucleotides Injectable Market Report Highlights:

Based on application, the eye segment held the largest revenue share of 63.9% in 2023. This large share is driven by the growing demand for non-invasive solutions to address various eye-related concerns. Polynucleotide injectables improve the appearance of fine lines, wrinkles, and skin laxity around the delicate eye area, which is often a key concern for aging individuals.
In terms of end use, the MedSpas segment held the largest revenue share of 50.1% in the polynucleotide injectable market, driven by consumers’ growing demand for non-invasive aesthetic treatments. Polynucleotides’ unique properties, which enable them to stimulate collagen production, enhance skin texture, and diminish the appearance of fine lines and wrinkles, have made these injectable treatments a highly sought-after option among MedSpa clients seeking natural and long-lasting aesthetic improvements.
The Asia Pacific polynucleotide market held the largest global revenue share of 50.5% in 2023 as the region is witnessing several key trends, including the emergence of domestic players offering low-cost products to expand market access and affordability.

Order your free sample copy of “Polynucleotides Injectable Market Report 2024 – 2030, published by Grand View Research

Polynucleotides Injectable Market Segmentation

Grand View Research has segmented the global polynucleotides injectable market based on application, end use, and region:

Polynucleotides Injectable Application Outlook (Revenue, USD Million, 2018 – 2030)
- Eyes
- Lips
- Forehead
- Jawline & Cheekbones
- Others
Polynucleotides Injectable End Use Outlook (Revenue, USD Million, 2018 – 2030)
- MedSpas
- Aesthetic & Cosmetic Centers
- Hospitals
Polynucleotides Injectable Regional Outlook (Revenue, USD Million, 2018 – 2030)
- North America
- - U.S.
- - Canada
- - Mexico
- Europe
- - UK
- - Germany
- - France
- - Italy
- - Spain
- - Denmark
- - Sweden
- - Norway
- Asia Pacific
- - Japan
- - China
- - India
- - Australia
- - South Korea
- - Thailand
- Latin America
- - Brazil
- - Argentina
- Middle East and Africa
- - South Africa
- - Saudi Arabia
- - UAE
- - Kuwait

List of Key Players in the Polynucleotides Injectable Market

PHARMA RESEARCH
BIOPLUS CO., LTD.
LG Chem
AMEELA
Mastelli
Pluryal
Promoitalia Laboratories.
Fox Pharma
BR Pharm
DermaFocus

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

Dental Implants Market: Innovations in Materials and Techniques Transforming Care

The global dental implants market size is expected to reach USD 9.62 billion by 2030, registering a CAGR of 9.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising demand for tooth replacement has provided good growth potential to the market. The increasing number of dental injuries owing to road accidents and sports injuries are some of the major factors boosting the market growth.

With growing aesthetic awareness, people are exploring more treatment options, which is leading to the growth of the market. For instance, as per the American Academy of Cosmetic Dentistry data, more than 95.0% of individuals across the globe believe that their smile is a vital social asset and nearly 84.0% revealed to be under increased pressure to perfect their smile, thus increasing the product demand. Dental implants are considered the only restorative technique that preserves and stimulates natural bone. Owing to the growing number of edentulous people, the demand for prosthetics is increasing, which is expected to be one of the major impact-rendering drivers for the market.

Access the Dental Implants Market Size, Share & Trends Analysis Report By Implant Type (Zirconium, Titanium), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2024 – 2030

Several industries have halted their services due to the COVID-19 pandemic. However, the dental care industry is greatly impacted by the significant decrease in elective procedures, many of which are being postponed or canceled so that hospitals can focus their resources on treating patients with COVID-19. Major Countries like the U.S and India procure raw materials and electronic components from China, which has disrupted the supply chain of many dental equipments and product manufacturers. However, with the decrease in the number of COVID-19 cases, hospitals are likely to begin scheduling elective procedures, depending on their capacity of admission and patients comfort level.

Dental Implants Market Report Highlights

The titanium segment held the largest share of more than 91.36% of the overall revenue in 2023 due to its wide applications, durability, and cost-effectiveness

The zirconium segment is anticipated to be the fastest-growing product segment over the forecast period due to better flexural strength, improved aesthetic appearance, and less corrosiveness as compared to titanium

North America dominated the global dental implants market and accounted for the maximum share of more than 35.64% in 2023 owing to high awareness about restorative treatments and the presence of established market players

Order your free sample copy of “Dental Implants Market Report 2024 – 2030, published by Grand View Research

Key Companies & Market Share Insights

Companies are focusing on strategic initiatives, such as the introduction of novel products through customization according to consumers’ needs, partnerships, collaborations, and mergers & acquisitions, to expand their product portfolio and extend leadership positions in the field of dental implantology. Moreover, the competition between key players will turn intense in the coming years as they are focusing more on geographical expansion, strategic collaborations, and partnerships through mergers & acquisitions. In May 2020, Straumann Group announced a new zygomatic implant solution for patients with severe jawbone loss in collaboration with Southern Implants. The new solution combines proven implant design features with the advantages of Straumann’s BLX and BLT implant prosthetic range.

Key Dental Implants Companies:

BioHorizons IPH, Inc.
Nobel Biocare Services AG
Zimmer Biomet Holdings, Inc.
OSSTEM IMPLANT
Institut Straumann AG
Bicon, LLC
Leader Italy
Anthogyr SAS
DENTIS
DENTSPLY Sirona
DENTIUM Co., Ltd.
T-Plus Implant Tech. Co.
KYOCERA Medical Corp.

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

Innovations in Antimicrobial Additives Enhance Hygiene and Safeguard Public Health

Antimicrobial additives have emerged as a crucial technology in consumer products and industrial applications. These additives are designed to inhibit the growth of microorganisms on various surfaces, thereby enhancing product longevity, hygiene standards, and overall safety. As the demand for antimicrobial protection continues to rise across sectors such as healthcare, packaging, textiles, and food processing, the global antimicrobial additives market is experiencing significant growth and evolution.

Antimicrobial additives are substances infused into materials during manufacturing to prevent the growth of bacteria, fungi, algae, and other microbes. They work by disrupting the cellular processes of microorganisms, thereby inhibiting their growth and reproduction. Common antimicrobial agents used in these additives include silver ions, copper ions, zinc pyrithione, quaternary ammonium compounds (QACs), and triclosan, among others.

Access the Antimicrobial Additives Market Size, Share & Trends Analysis Report 2024-2030, published by Grand View Research

Market Drivers

Increasing awareness about the importance of cleanliness and hygiene, especially in healthcare settings and public places, is a significant driver of the antimicrobial additives market. Consumers are more conscious about the transmission of infections and are seeking products that offer antimicrobial protection. Hospitals, clinics, and other healthcare facilities require stringent infection control measures. Antimicrobial additives in medical devices, equipment, and surfaces help in reducing the risk of healthcare-associated infections (HAIs).

In the consumer goods sector, antimicrobial additives are incorporated into products such as textiles, household appliances, and personal care items. The desire for products that stay cleaner and fresher for longer periods is boosting the demand for antimicrobial-treated goods.

Regulatory bodies across the globe are increasingly emphasizing hygiene and safety standards in various industries. This regulatory support encourages manufacturers to incorporate antimicrobial additives into their products to meet compliance requirements.

Challenges of the Antimicrobial Additives Market

Environmental concern is the biggest challenge in the market for antimicrobial additives. Some antimicrobial additives, such as triclosan, have faced scrutiny due to their potential environmental impact and health concerns. Regulatory restrictions and consumer preferences for eco-friendly alternatives pose challenges to the market growth of certain antimicrobial agents.

There is ongoing concern about the development of antimicrobial resistance among microorganisms when exposed to antimicrobial agents over time. This necessitates continuous research and development efforts to innovate new antimicrobial technologies. Moreover, the incorporation of antimicrobial additives can add to the production costs of materials and products. Manufacturers need to balance the benefits of antimicrobial protection with cost-effectiveness to maintain competitiveness in the market.

Order Your Sample Copy of the Antimicrobial Additives Market Size, Share & Trends Analysis Report By Type (Organic, Inorganic), By Application (Plastics, Paints & Coatings, Pulp & Paper), By End-use, By Region, And Segment Forecasts, 2024 – 2030

Global Market Insights

The global antimicrobial additives market stood at USD 3.11 billion in 2023. This is expected to cross USD 5.60 billion by 2030, growing at a compound annual growth rate (CAGR) of 9.0%. The industry is dominated by the Asia Pacific region, which accounted for over 38.0% share of the global revenue in 2023. The regional market is driven by the growth of major industries such as automotive, construction, healthcare, food and beverage, and packaging, among others. The robust manufacturing base of the automotive industry in countries such as China, India, and Japan is expected to boost the demand for antimicrobial additives in the near future.

The North American region also holds a significant share in the antimicrobial additives market due to stringent regulatory standards and high healthcare expenditure. At the same time, increasing consumer awareness regarding hygiene and growing demand in industries such as food processing and packaging are driving market growth in Europe.

Competitive Landscape and Future Outlook

The antimicrobial additives market is highly competitive, with several key players dominating the industry. Companies are focusing on research and development to introduce innovative antimicrobial technologies and expand their product portfolios. Strategic collaborations, mergers, and acquisitions are also prevalent strategies among market players to strengthen their market position. For example, BioCote Ltd. entered into a strategic partnership with Eco Finish in July 2023 to leverage the technology for antimicrobial surfaces in residential & commercial pools, delivering additional safety and protection for swimmers.

NanoBioMatters Industries S.L, RTP Company, BASF SE, Milliken Chemical, Microban International, BioCote Ltd., Clariant AG, Momentive Performance Materials Inc., Life Materials Technologies Ltd., PolyOne Corporation, SteriTouch Limited, Sanitized AG, LyondellBasell Industries Holdings B.V., Dow Inc., Plastics Color Corporation, and Lonza are some of the key companies operating in the global antimicrobial additives market.

The future of the antimicrobial additives industry looks promising with continued advancements in technology and increasing application across various industries. Key trends shaping the market include:

The development of sustainable antimicrobial solutions.
Integration of antimicrobial properties in smart textiles and wearable devices.
The expansion of antimicrobial additives into new application areas.

Although the market faces some challenges, such as environmental concerns and regulatory scrutiny, ongoing innovation and increasing awareness about infection control are expected to drive market growth. As global demand for antimicrobial protection continues to rise, stakeholders across industries are poised to capitalize on the expanding opportunities presented by this dynamic market.

Explore Horizon, the world’s most expansive market research database

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Endoscopes Market Driven by Growing Prevalence of Gastrointestinal, Respiratory, and Urological Disorders Requiring Early Detection

The global endoscopes market size is expected to reach USD 37.1 billion by 2030, registering a CAGR of 8.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growing awareness levelsabout minimally invasive surgical procedures and the increasing prevalence of chronic disorders are the major factors accelerating the market growth. The benefits, such as less surgery-related blood loss, no muscle cutting, and quicker recovery, offered by minimally invasive surgeries boost the adoption of endoscopic procedures over traditional/open invasive surgeries. In addition, advancement in endoscopic technology and rapid increase of its application to diagnose and treat various diseases are other key factors anticipated to propel the market growth over the forecast years. The flexible endoscopes product segment dominated the market in 2023.

This is attributed to the high demand for these devices considering their unique features, such as the ability to reach viscera and cavities, better safety and efficiency, and improved ergonomic features. These devices are most commonly used in several endoscopic procedures, such as esophagogastroduodenoscopy (EGD), bronchoscopy, sigmoidoscopy, laryngoscopy, pharyngoscopy, nasopharyngoscopy, rhinoscopy, and colonoscopy procedures, which supports the product demand and segment growth.

Access the Endoscopes Market Size, Share & Trends Analysis Report 2024-2030, published by Grand View Research

In 2023, the outpatient facilities end-use segment dominated the market. Increasing adoption of endoscopes across outpatient facilities such as ambulatory surgery centers and diagnostic clinics for the early diagnosis and detection of several life-threatening diseases is supporting the segment growth. In addition, the introduction of keyhole endoscopic surgeries with minimal discomfort and faster recovery time also boosts the segment growth. In addition, North America held the largest revenue share in 2023 owing to its better healthcare infrastructure, high preference for minimally invasive surgical procedures among individuals, and quick adoption of advanced technologies. The increasing burden of functional gastrointestinal disorders and cancer is anticipated to further propel market growth in this region. For instance, as per the data reported by the National Cancer Institute, in 2020, over 1.8 million new cancer cases were estimated to be diagnosed in the U.S.

Several industry consolidation activities, such as mergers & acquisitions, and partnerships have resulted in a strong market share of the global market. Manufacturers in the market are also focusing on launching new endoscopes with advanced features as per patients’ requirements, to enhance their market share and consumer base. For instance, in January 2021, Karl Storz SE & Co. KG announced the launch of Image 1 S Rubina, which combines multimode fluorescence imaging with 4K resolution for endoscopy procedures. The toggling between white light and fluorescence modes allows surgeons to set it per surgical needs.

Order Your Sample Copy of the Endoscopes Market Size, Share & Trends Analysis Report By Product (Disposable, Flexible, Rigid), By End Use (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2024 – 2030

Endoscopes Market Report Highlights

Based on product, the flexible endoscopes segment held the largest revenue share in 2023 owing to its unique features, such as the ability to reach viscera & cavities, better safety & efficiency, and improved ergonomic features

In terms of end-use, the outpatient facilities segment held the largest revenue share in 2023 due to widespread adoption of keyhole or minimal invasive surgeries across these facilities

North America dominated the market in 2023 owing to various factorsincluding the increasing burden of functional gastrointestinal disorders, improved healthcare infrastructure, and the growing preference for minimally invasive surgeries to curb healthcare spending.

Recent Developments

In November 2023, Olympus Corporation (Olympus), launched EVIS X1, its next-generation endoscopy system in China. This endoscopy system has been demonstrated at the 6th annual China International Import Expo that was held in Shanghai from November 5th -10th.

In March 2023, AIG Hospitals in Hyderabad launched a Center of Excellence (CoE) in collaboration with Boston Scientific. This collaboration aims to enhance healthcare services by providing advanced treatment options and expertise in various medical fields.

In January 2023, FUJIFILM India has launched FushKnife, a diathermic slitter and ClutchCutter, a rotatable forceps. The products were introduced at the 63rd Annual Conference of Indian Society of Gastroenterology-ISGCON in Jaipur.

Explore Horizon, the world’s most expansive market research database

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

IVF Services Demand Surges as Couples Seek Advanced Assisted Reproductive Technologies

The rising infertility among the male and female population across the globe is the primary driving factor for the growth of the in vitro fertilization market. Other main contributing factors to the growth of the market include rising reproductive tourism and the growing awareness among the population regarding in vitro fertilization. According to WHO, approximately 1 in 6 people(17.5% of the global population) worldwide – have infertility, which indicates a growing requirement for infertility treatments.

The change in lifestyle and increase in the average age of marrying, as well as an increase in the average age of conceiving a first child, is increasing globally. As the number of individuals opting for IVF treatments is growing, this trend is fueling the growth of in vitro fertilization treatments. In addition, many career-oriented women are opting for freezing their eggs and planning to have a child at a later stage in life. This growing reliance on fertility methods is anticipated to boost the IVF market. According to a Grand View Research report, the worldwide market for In vitro fertilization is projected to reach a value of USD 37.4 billion by the year 2030, at a compound annual growth rate of 5.54% over the forecast period of 2024 to 2030.

Access the In Vitro Fertilization Market Size, Share Trends Analysis Report 2024-2030, published by Grand View Research

As infertility is an issue that warrants both sensitivity and privacy, IVF service providers face the challenge of developing trust and authenticity through their digital platforms. Modern business requirements necessitate innovative methods of creating awareness about a particular cause or brand. Therefore, a virtual presence of all the entities involved (clinics, hospitals, and manufacturers) in the IVF process is recommended to create awareness about the treatments and their advantages to the individuals seeking this treatment.

Advantages of IVF Treatment

Genetic Testing Prior to IVF

The pre-implantation genetic testing (PGT) is a test that helps in identifying genetic disorders in embryos prior to their implantation in the IVF treatment. Couples who have a family history of certain disorders, unwanted traits, or genetic diseases can certainly overcome these disadvantages through the PGT as it helps them select an embryo that is free from genetic disorders, thus reducing the risk of passing the unwanted genetic trait to their offspring.

Pregnancy Time Management

Couples seeking IVF treatment other than infertility reasons can plan their pregnancy according to their preferred time through embryo or egg cryopreservation. Couples who were busy during their initial years of marriage or because of certain career commitments can definitely opt for IVF treatments as it has a high success rate and is certainly a beacon of hope for women over the age of 40 who suffer from a decline in age-related fertility.

Integration of Artificial Intelligence in IVF

In the past few years, the integration of time-lapse imaging and artificial intelligence (AI) into IVF procedures has demonstrated encouraging outcomes in enhancing the likelihood of success. Such technological progress has rendered IVF a more attainable and successful option for couples facing fertility challenges. For example, in May 2023, a collaboration between Genea Biomedx and AIVF introduced a cost-effective, personalized IVF treatment package. This comprehensive system combines the Geri time-lapse incubator from Genea Biomedx with the EMA AI platform developed by AIVF.

Order Your Sample Copy of the In Vitro Fertilization Market Size, Share & Trends Analysis Report By Instrument (Equipment, Disposable Devices, Culture Media), By Procedure Type (Fresh Nondonor, Frozen Nondonor), By Providers, By Region, And Segment Forecasts, 2024 – 2030

Predictive Analytics:

AI algorithms can predict the success ratio for a specific IVF cycle by analyzing huge amounts of data, including genetic information, medical history, and hormonal levels. This can benefit both doctors and patients as AI can more effectively increase the probability of a successful pregnancy.

Back-to-Back IVF Cycles

The advantages of back-to-back IVF cycles are significant. Women opting for IVF can undertake several cycles back-to-back, bypassing the need to wait for the commencement of a menstrual cycle. This approach can be beneficial for couples eager to conceive promptly or for those who have urgent reasons to opt for IVF, including fertility reduction due to advancing age or health issues that could impact fertility.

Solution to Male Infertility

Intracytoplasmic Sperm Injection (ICSI) is a procedure that involves injecting a single sperm directly into an egg, offering a significant advantage for couples dealing with male infertility. Despite the ongoing debate about its advantages and disadvantages, it’s clear that ICSI can enhance fertilization prospects and boost IVF success rates for couples contending with male infertility, particularly when there are natural obstacles to sperm fertilizing the egg.

In Conclusion

As technology advances, IVF continues to evolve, promising greater success rates and making dreams of parenthood a reality for many. Its role in fertility preservation further gives hope to individuals, granting them autonomy over their reproductive choices. IVF is not just a treatment but a journey of hope, culminating in the joy of life’s most precious gift—a child.

Explore Horizon, the world’s most expansive market research database

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Industrial Air Filtration Market Evolving to Meet Stringent Emissions Regulations Worldwide

Rapid industrialization and rising environmental concerns are navigating the industrial air filtration market. The world is aware of its carbon footprints, and industries willingly focus on air filtration in their respective plants. Rising air pollution due to carbon and other pollutants such as pollutants such as nitrogen oxide, ammonia, and mercury are causing harm to the environment. Therefore, according to Grand View Research, the global industrial air filtration market is poised for significant growth, with an estimated size of around USD 7.43 billion in 2023 and a projected compound annual growth rate (CAGR) of 6.3% from 2024 to 2030.

Access the Industrial Air Filtration Market Size, Share & Trends Analysis Report 2024-2030, published by Grand View Research

Driving Factors of the Industrial Air Filtration Market

Multiple factors, such as international mandates like the UN Framework Convention on Climate Change, Montreal Protocol, Kyoto Protocol, COP24, and others, drive the market. In addition, respective countries’ government regulations increase workplace safety awareness and maintain high-quality air standards across various industries.

As the global economy continues to evolve, this market is expected to witness a surge in demand, particularly in key sectors such as cement, food and beverage, metal, power, pharmaceutical, manufacturing plants, chemical and petrochemical, paper and wood processing, and agriculture.

Benefits of Air Filtration in Industries

Reduces carbon emissions and helps to improve air quality
Effective in removing impure pollutants and contaminants
Increases the efficiency of workplaces by adhering to industry standards
Protect employees from hazardous air pollutants
Removes solid dust particles from polluted gases

The Types of Industrial Air Filtration Products
Industrial air filtration includes a diverse range of products, encompassing technologies and solutions. For example, cartridge collectors and filters, baghouse filters, mist collectors, fume collectors, and High-Efficiency Particulate Air (HEPA) filters are among the prominent product categories that cater to industrial facilities’ diverse needs.

Cartridge collectors and filters, for instance, offer efficient particulate removal, making them suitable for applications where fine dust and debris are a concern. On the other hand, baghouse filters excel in handling larger particulates, often found in cement, metal, and power generation industries.

Order Your Sample Copy of the Industrial Air Filtration Market Size, Share & Trends Analysis Report By Product, By End Use (Cement, Food & Beverage, Metal, Power, Pharmaceutical), By Region, And Segment Forecasts, 2024 – 2030

Mist collectors and fume collectors play a vital role in controlling airborne contaminants, such as oil mists and welding fumes, ensuring a safer working environment in manufacturing industries. HEPA filters, renowned for their exceptional filtration capabilities, are widely used in industries, such as pharmaceuticals and electronics manufacturing, where high-purity air is paramount.

As the market continues to evolve, industry players are actively investing in research and development to enhance the performance, energy efficiency, and sustainability of their filtration solutions. Advancements in materials, sensor technology, and data analytics are driving the industry forward, enabling more intelligent and adaptive air filtration systems.

Furthermore, the increasing emphasis on environmental sustainability and the reduction of greenhouse gas emissions have led to an increased adoption of energy-efficient and eco-friendly industrial air filtration systems. Manufacturers are exploring innovative technologies, such as renewable energy-powered units and advanced filtration media, to minimize the environmental impact of industrial operations.

Final word

An increasing focus on workplace safety and a growing concern for the environment is driving the market growth for industrial air filtration. This presents significant growth opportunities for manufacturers, service providers, and end-users across various industries. By staying abreast of the latest trends, making use of technological advancements, and adapting to the changing needs of diverse industries, stakeholders can stay competent in this expanding market.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com/sector-reports-list

Advancements in Veterinary Imaging Instrument Sector: Trends and Opportunities from 2023 to 2030

Veterinary Imaging Instrument Industry | Forecast 2030

Grand View Research’s Veterinary Imaging Instrument industry data book is a collection of market sizing information & forecasts, regulatory data, competitive benchmarking analyses, macro-environmental analyses, and technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.

The global market size for the veterinary imaging instrument was estimated at USD 1.44 Billion in 2021 and is anticipated to increase at a CAGR of 5.7% from 2022 to 2030. The market is expected to expand because of the rising pet expenditure, the number of veterinarians in developed countries, and product launches. For instance, the helical fan beam CT system has enabled quicker scanning for routine imaging of the sinuses and teeth in horses, according to the Journal of the American Veterinary Medical Association in 2020. As a result of this quality, the helical fan beam CT system has been accepted by professionals and is currently in use.

Access the Global Veterinary Imaging Instrument Industry Data Book, 2023 to 2030, compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking, macro-environmental analyses, and regulatory & technological framework studies

Moreover, the rising prevalence of cardiovascular disease, arthritis, lameness, and the occurrence of bone injuries in pet population is further anticipated to fuel market growth. North America held the lion’s share in the regional market. However, competition in the emerging market is increasing because nations owe to demand from consumers’ end and veterinary infrastructure development.

Key veterinary imaging equipment manufacturers are adopting strategies such as JV, M&A etc that would provide a wider consumer base and geographic footprint. For instance, Zomedica Corp. highlighted a successful acquisition of Assisi’s LOOP and Calmer Canine product lines as well as assets of Revo2’s imaging products in its Q3 2022 report. The combination of these two product lines would give veterinarians the chance to better care for the animals they treat while also benefiting their clinics financially, ultimately resulting in an increase in business revenue as user adoption of the products rises.

Veterinary X-ray Market Insights

The global veterinary x-ray market size is estimated at USD 654.39 million in 2022 and is expected to grow at a lucrative compound annual growth rate (CAGR) of 6.31% over the forecast period. Demand for veterinary X-rays has increased due to a greater emphasis on animal health innovation, a greater need for diagnostics, increased pet adoption, and increased adoption of radiography in veterinary orthopedics, dentistry, and in several other indications. Furthermore, the increasing incidence of zoonotic diseases has increased the demand for effective diagnostic solutions, which is expected to drive global market growth. Moreover, technological advancements in X-ray diagnostics are further expected to boost adoption. For instance, in September 2022, SK Telecom from Korea launched an AI based diagnosis assistance X-ray service called X Caliber, capable of delivering quick analysis to the veterinarian.

Order your copy of the Free Sample of “Veterinary Imaging Instrument Industry Data Book – Veterinary X-Ray, Veterinary Ultrasound, Animal MRI and Animal/Veterinary CT Imaging Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 – 2030” Data Book, published by Grand View Research

The emergence of covid-19 had an impact on the entire healthcare sector, including veterinary medicine. The covid-19 was found to have slightly halted the growth of the market since several non-essential surgeries are restricted across the globe during the pandemic. Furthermore, strict restrictions on the transportation of individuals and goods led to a restricted patient influx in veterinary centers. Similarly, the shortage of skilled veterinarians, combined with suspended/postponed elective surgeries, significantly disrupted the activities of veterinary facilities, having a slightly negative impact on market providers.

Moreover, the pandemic has risen pet ownership in some countries, resulting in even more animal care delivery, which had increased the demand for veterinary diagnostic testing. For instance, the American Society for the Prevention of Cruelty to Animals (ASPCA) reported in May 2021 that one out of each five families had adopted a cat or dog since the early stages of the COVID-19 pandemic. Adoptions like these during the pandemic brought more attention to companion animal diagnosis and treatment. As a result, it is expected that it will boost the demand for the market during the forecast period.

Go through the table of content of Veterinary Imaging Instrument Industry Data Book to get a better understanding of the Coverage & Scope of the study

Veterinary MRI Market Insights

The global veterinary MRI market size was valued at USD 205.93 million in 2022 and is expected to expand at a lucrative compound annual growth rate (CAGR) of 7.38% from 2023 to 2030. The growth is primarily driven by the increasing pet humanization, technological advancements, initiatives by key companies, and the adoption of pet insurance. For instance, Time Medical Systems based in Hong Kong, offers 4 magnetic resonance imaging (MRI) scanners in the veterinary space namely, Panion Premie, Panion Pro, Panion, and Panion+. Panion for example is a dedicated open veterinary MRI machine that provides affordable diagnostic MR scans for pets.

The COVID-19 pandemic significantly impacted the market with supply chain challenges and dampened demand. However, it also led to increased awareness regarding animal health, an increase in vet visits, and concerns over zoonoses. The overall impact on the market was thus neutral and the sale of veterinary MRIs is anticipated to continue rising in the coming years. In March 2022 Hallmarq Veterinary Imaging, for instance, reported a key milestone of completing 300,000 animal scans using its MRI and CT machines.

Technological advancements are a key driver contributing to market growth. Companies are involved in the R&D of products, product launches, and upgrades to overcome challenges and increase their market share. For example, in November 2022, Hallmarq Veterinary Imaging launched a zero-helium small animal MRI machine in response to the shortage of helium supply, soaring helium prices, and enhanced sustainability. The new machine does not require helium or any additional power to cool the MRI magnet coils. It instead uses vacuum technology and a conduction-based cooling system.

Competitive Landscape

Key players operating in the veterinary imaging instrument market are IDEXX Laboratories, Inc.; Canon Medical Systems Corporation; FUJIFILM Holdings America Corporation, Samsung, Heska Corporation, and Butterfly Network, Inc. Some of the major private participants in the market are Carestream Health; Midmark Corporation; ESAOTE SPA, and SOUND. These players incorporate various strategic initiatives, such as partnerships, sales & marketing activities, mergers & acquisitions, service expansion, integrated offerings, and product launches, to strengthen their market presence.

Check out more Industry Data Books, published by Grand View Research

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com/sector-reports-list

Advancements in Neurodegenerative Disease Therapeutics: A Comprehensive Review

Neurodegenerative Disease Therapeutics Industry | Forecast 2030

Grand View Research’s neurodegenerative disease therapeutics industry data book is a collection of market sizing & forecasts insights, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses studies. Within the purview of the database, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research.The following data points will be included in the final product offering in two reports and one sector report overview.

The global neurodegenerative disease markets combine to account for USD 8.33 billion revenue in 2021, which is expected to reach USD 28.15 billion by 2030, growing at a cumulative rate of 15.6% over the forecast period. The combination bundle is designed to provide a holistic view of these highly dynamic market spaces.

Access the Global Neurodegenerative Disease Therapeutics Industry Data Book, 2023 to 2030, compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking, macro-environmental analyses, and regulatory & technological framework studies

Parkinson’s Disease Treatment Market Insights

The global Parkinson’s disease treatment market size was valued at USD 4.28 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 12.1% from 2022 to 2030. The increasing geriatric population, which is exposed to a high risk of developing Parkinson’s Disease (PD), the high burden of PD in western countries, and the strong product pipeline of disease-modifying therapies are anticipated to be major drivers for the industry. According to the International Parkinson and Movement Disorder Society, in 2020, around 9.4 million individuals had PD worldwide. Moreover, PD affects around 1% of the total population over the age of 60 years, which rises to 5% for the population over the age of 85 years.

Moreover, according to a UN report, there were about 727 million people aged 65 years & above globally in 2020. In addition, the number of individuals aged 80 years and above is projected to double by 2050, reaching more than 1.5 billion globally. Hence, the rise in the prevalence of PD has paved the way for key pharmaceutical players to undertake extensive market growth in this sector. The availability of different dosage forms can enable product differentiation for pharmaceutical companies, resulting in greater profits. NeuroDerm is developing ND0612 for the treatment of patients with moderate-to-severe PD, for whom oral medications are no longer effective.

In addition, LY03003 (Rotigotine ER Microsphere) and P2B001 (extended-release (ER) formulations of pramipexole and rasagiline) are currently being developed by Luye Pharma Group and Pharma Two B respectively. Chronic PD requires treatment for a long duration, along with critical care. Treatments of such illnesses require high expenditure. The treatment cost for PD varies depending on the region. According to a research study, the direct annual medical cost per PD patient is estimated to be around USD 10,043 to USD 12,491 in the U.S.; out of this, prescription drugs accounted for around 14-22%. Owing to favorable healthcare policies and reimbursement scenarios in developed countries such as the U.S., the overall cost burden on an individual patient is reduced.

Order your copy of the Free Sample of “Neurodegenerative Disease Therapeutics Industry Data Book – Parkinson’s Disease Treatment and Alzheimer’s Therapeutics Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 – 2030” Data Book, published by Grand View Research

Alzheimer’s Therapeutics Market Insights

The global alzheimer’s therapeutics market size was valued at USD 4.05 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 19.99% from 2023 to 2030. The rising prevalence of Alzheimer’s Disease (AD) and approval of disease-modifying therapies are expected to fuel market growth. According to the NCBI, in 2021, about 6.2 million people aged 65 and above living in America were suffering from Alzheimer’s disease, which is estimated to increase to around 13.8 million by 2060. Women are more prone to be diagnosed with Alzheimer’s disease than men due to the longer life expectancy of women. Moreover, Alzheimer’s disease is becoming the most common cause of death in neurodegenerative diseases and a common cause of physical disability that require immediate treatment.

The impact of the COVID-19 pandemic on the market was negative due to strict measures undertaken by the government such as lockdown to control infection spread. During the pandemic, the prescription rate for drugs used to treat Alzheimer’s was lowered due to a decline in patient visits to clinics and hospitals for treatment and fear of COVID infection, thereby restraining market growth.

The introduction of new highly sensitive cloud-based cognitive assessment systems will assist pharmaceutical companies in identifying the effects of drugs on patients. This will enable pharmaceutical companies to effectively evaluate the cognitive efficacy and safety of pipeline drugs. For instance, Cambridge Cognition’s Cantab Connect product has been specifically developed to measure the effectiveness of drugs for mild, moderate, and prodromal AD. The adoption of such technology is expected to enhance the chances of product approvals, consequently driving the Alzheimer’s disease treatment market.

The uncertainty, failure, and discontinuation of the clinical trials of Alzheimer’s drugs lead to the availability of limited treatment alternatives. This increases the costs related to research and development. Hence, it is expected to restrain market growth. For instance, Amgen Inc. and Novartis AG discontinued their Phase 2 clinical trial for CNP520 (umibecestat), a BACE1 inhibitor for Alzheimer’s disease, in July 2019, due to the lack of desired results.

Go through the table of content of Neurodegenerative Disease Therapeutics Industry Data Book to get a better understanding of the Coverage & Scope of the study

Competitive Landscape

Competitive rivalry in this market is likely to be high due to increasing number of mergers, acquisitions, and partnerships undertaken by major players globally. Many established and clinical-stage pharmaceutical companies are involved in the development of novel therapies & drugs to target people with unmet clinical needs. Furthermore, the companies are focusing on the development of strategic alliances and research collaborations with competitors. For instance, in January 2022, Mindset Pharma Inc. and McQuade Center for Strategic Research and Development, LLC entered into a partnership to promote the advancement of psychedelic medications.

Some of the key players in the neurodegenerative disease industry are Eisai Co., Ltd., AbbVie Inc. (Allergan Plc.), Merck & Co., Inc., Adamas Pharmaceuticals, Inc., Novartis AG,H. Lundbeck A/S, Cerevel Therapeutics, Biogen, Daiichi Sankyo Company, Limited, F. Hoffmann La Roche Ltd., TauRx Pharmaceuticals Ltd., Johnson & Johnson Services, Inc., AC Immune, Teva Pharmaceutical Industries Ltd., and GlaxoSmithKline plc. (GSK). Key players in the market adopt this strategy to strengthen their product portfolio and offer diverse, technologically advanced, & innovative products to patients. For instance, in August 2022, Knight Therapeutics, Inc. re-launching Exelon (Rivastigmine) developed by Novartis after receiving marketing authorization in Brazil. This launch is expected to boost the Alzheimer’s therapeutics market in Latin America.

Check out more Industry Data Books, published by Grand View Research

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com/sector-reports-list

Advancements in Cell Culture Technology Propel Industry Growth in 2023-2030

Cell Culture Industry | Forecast 2030

Grand View Research’s Cell Culture Industry databook is a collection of market sizing & forecasts insights, market dynamics & trends, opportunity assessment, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses studies. Within the purview of the databook, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research.The following data points will be included in the final product offering in four reports and one sector report overview.

Cell Culture industry data book is a combination of the market data from four reports namely, cell culture, cell culture media, 3D cell culture, and primary cell culture market. Cell culture market was valued at USD 21.05 Billion in 2021 with CAGR of 11.86% during 2022-2030. Cell culture media market and primary cell culture market are also growing at the CAGR of 12.13% and 10.66% respectively.

Access the Global Cell Culture Industry Data Book, 2023 to 2030, compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking, macro-environmental analyses, and regulatory & technological framework studies

Advancements in these techniques such as 3D cell culture and its growing adoption for biopharmaceuticals manufacturing, tissue engineering, and drug development applications are projected to boost the demand for cell culture products. Also, large number of oncology focused research trials and broadening scope of gene therapy applications are also expected to drive the market growth. In addition, development in regenerative medicine market space and high unmet medical needs in emerging markets are expected to drive the adoption of cell culture technologies. The combination bundle of these reports is designed to provide a holistic view of these highly dynamic market spaces in this industry.

Cell Culture Market Insights

The global cell culture market size was estimated at USD 16.59 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 11.32% from 2023 to 2030. Its growth can be attributed to the rapid adoption of cell culture techniques to develop substrates for the safe production of viral vaccines, and the rising global demand for advanced therapy medicinal products. Furthermore, novel three-dimensional cell culture techniques and the growing need for them in biopharmaceutical development & vaccine production are expected to drive the market growth over the forecast period. The COVID-19 pandemic has presented researchers with the opportunity to investigate the novel contagious virus for the creation of therapeutic and diagnostic tools.

Order your copy of the Free Sample of “Cell Culture Industry Data Book – Cell Culture, Cell Culture Media, 3D Cell Culture, Primary Cell Culture Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 – 2030” Data Book, published by Grand View Research

Cell Culture Media Market Insights

The global cell culture media market size was estimated at USD 4.73 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 12.54% from 2024 to 2030. Cell culture media is generally a gel or liquid including compounds required to regulate and support the growth of cells or microorganisms used in the manufacturing of biopharmaceuticals. Culture media is a critical ingredient in biopharmaceutical manufacturing, aiding the growth of cells, and is the fastest-growing segment within this market. This growth is mainly driven by growing demand for biopharmaceuticals, favorable governmental policies, and increasing investment in R&D.

3D Cell Culture Market Insights

The global 3D cell culture market size was estimated at USD 1.57 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 11.22% from 2024 to 2030. The growth of the market can be attributed to the rising efforts to develop potential alternatives to animal-based testing and the availability of funding programs for research. Moreover, consistent efforts in R&D activities by biopharmaceutical companies for drug development & discovery, and emphasis on the adoption of 3D cell cultures in cancer research are other factors anticipated to fuel market growth over the projected period. Animal models are largely used in cellular-based studies for studying the outlook of various diseases. However, they carry several demerits such as a lack of response accuracy, differences in response from different species, etc. Thus, to manage these issues, various government organizations are involved in promoting alternative ways for drug development.

Go through the table of content of Cell Culture Industry Data Book to get a better understanding of the Coverage & Scope of the study

Primary Cell Culture Market Insights

The global primary cell culture market size was estimated at USD 4.87 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 13.3% from 2024 to 2030. The market growth can be primarily attributed to the increasing prevalence of chronic conditions, such as cancer, infections, autoimmune diseases, diabetes mellitus, cardiovascular diseases, and neprological diseases. This has led to an increase in research, facilitating the high adoption of primary cell cultures.

Furthermore, the growing need for primary cell culture is being driven by increased research to find novel treatments. Cancer is becoming increasingly prevalent all across the world. According to WHO projections, the number of cancer deaths worldwide will continue to climb and will reach over 17 billion by 2030. Moreover, as per American Cancer Society (ACS) Journals published in February 2021, there are 19.3 million cancer cases worldwide, and 10.0 million new cancer cases were recorded in 2020. A rapid growth in incidence of cancer across the globe will lead to an increased demand for novel therapeutics, hence anticipated to propel market growth.

Competitive Landscape

Competitive rivalry in the cell culture industry is high due to the presence of a large number of both well-established players and small- to mid-sized companies as well as CROs in the market space. Some of the major players are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Sartorius AG, Eppendorf AG, Merck KGaA, Becton, Dickinson and Company, PromoCell GmbH, and Lonza Group AG among many others. These market players are involved in the manufacturing of various products associated with this industry including cell media, reagents, consumables, and equipment along with certain services.

Check out more Industry Data Books, published by Grand View Research

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com/sector-reports-list